Jochen Utikal

50PUBLICATIONS

183CO-AUTHORS

Molecular targetsPredictive and prognostic markersMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (50)

Sort by Publication Date:

|Jun 03, 2026

After a Decade of Therapy Revolution in Cutaneous Melanoma-Perspectives on Emerging Treatment Strategies.

|Feb 27, 2026

COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant Melanoma.

Michael Weichenthal, Dirk Debus, Lisa Zimmer

|Oct 16, 2025

Dermal Mitoses Correlate with Surgical Burden in Lentigo Maligna Melanoma: PRAME for Margin Assessment.

Thomas Leibing, Clara Ziemann, Cyrill Géraud

|Oct 04, 2025

The neural crest-associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy.

Nina Wang, Qian Sun, Daniel Novak

|Jul 27, 2025

Direct transdifferentiation of tumorigenic melanoma cells induces tumor cell reversion.

Yiman Wang, Ke Liu, Yuxin Zhang

|Jun 12, 2025

Generation and functional analysis of melanoma antigen-specific CD8+ T cells derived from S/MAR vector-transfected human induced pluripotent stem cells.

Juliane Poelchen, Sandra Pardo, Daniel Novak

Pageof 9

Frequent Collaborators

10 joint publications

Titus Josef Brinker

Viktor Umansky

Dirk Schadendorf

Bastian Schilling

Markus V Heppt

Achim Hekler

Wiebke Sondermann

Michael Weichenthal

Carola Berking

Eva Krieghoff-Henning

Frequent Collaborators

10 joint publications

Titus Josef Brinker

9 joint publications

Viktor Umansky

9 joint publications

Dirk Schadendorf

7 joint publications

Bastian Schilling